363 related articles for article (PubMed ID: 27254748)
21. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
[TBL] [Abstract][Full Text] [Related]
22. Impact of ART on the fertility of HIV-positive women in sub-Saharan Africa.
Yeatman S; Eaton JW; Beckles Z; Benton L; Gregson S; Zaba B
Trop Med Int Health; 2016 Sep; 21(9):1071-85. PubMed ID: 27371942
[TBL] [Abstract][Full Text] [Related]
23. Survival of people aged 50 years and older by HIV and HIV treatment status: findings from three waves of the SAGE-Wellbeing of Older People Study (SAGE-WOPS) in Uganda.
Mugisha Okello J; Nash S; Kowal P; Naidoo N; Chatterji S; Boerma T; Seeley J
AIDS Res Ther; 2020 May; 17(1):17. PubMed ID: 32410634
[TBL] [Abstract][Full Text] [Related]
24. Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study.
Murray CJ; Lopez AD
Lancet; 1997 May; 349(9062):1347-52. PubMed ID: 9149696
[TBL] [Abstract][Full Text] [Related]
25. One world, one hope: the cost of providing antiretroviral therapy to all nations.
Hogg RS; Weber AE; Craib KJ; Anis AH; O'Shaughnessy MV; Schechter MT; Montaner JS
AIDS; 1998 Nov; 12(16):2203-9. PubMed ID: 9833862
[TBL] [Abstract][Full Text] [Related]
26. The road to success. Long-term prognosis for persons living with HIV in Denmark - time trends and risk factors.
Lohse N
Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836803
[TBL] [Abstract][Full Text] [Related]
27. Contribution of AIDS to the general mortality in Central Africa: evidence from a morgue-based study in Brazzaville, Congo.
Pictet G; Le Coeur S; M'Pelé P; Brouard N; Lallemant M
AIDS; 1998 Nov; 12(16):2217-23. PubMed ID: 9833864
[TBL] [Abstract][Full Text] [Related]
28. Overdose mortality is reducing the gains in life expectancy of antiretroviral-treated people living with HIV in British Columbia, Canada.
St-Jean M; Dong X; Tafessu H; Moore D; Honer WG; Vila-Rodriguez F; Sereda P; Hogg RS; Patterson TL; Salters K; Barrios R; Montaner JSG; Lima VD
Int J Drug Policy; 2021 Oct; 96():103195. PubMed ID: 33773878
[TBL] [Abstract][Full Text] [Related]
29. The Effect of Antiretroviral Treatment on Health Care Utilization in Rural South Africa: A Population-Based Cohort Study.
Hontelez JA; Tanser FC; Naidu KK; Pillay D; Bärnighausen T
PLoS One; 2016; 11(7):e0158015. PubMed ID: 27384178
[TBL] [Abstract][Full Text] [Related]
30. Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010.
Wang H; Dwyer-Lindgren L; Lofgren KT; Rajaratnam JK; Marcus JR; Levin-Rector A; Levitz CE; Lopez AD; Murray CJ
Lancet; 2012 Dec; 380(9859):2071-94. PubMed ID: 23245603
[TBL] [Abstract][Full Text] [Related]
31. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
[TBL] [Abstract][Full Text] [Related]
32. The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
Dutta A; Barker C; Kallarakal A
PLoS Med; 2015 Nov; 12(11):e1001907; discussion e1001907. PubMed ID: 26599990
[TBL] [Abstract][Full Text] [Related]
33. Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: a secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), Ndhiwa (Kenya) and Chiradzulu (Malawi).
Chihana ML; Huerga H; Van Cutsem G; Ellman T; Goemaere E; Wanjala S; Masiku C; Szumilin E; Etard JF; Maman D; Davies MA
Glob Health Action; 2019; 12(1):1679472. PubMed ID: 31679482
[No Abstract] [Full Text] [Related]
34. Reaching the 'first 90': Gaps in coverage of HIV testing among people living with HIV in 16 African countries.
Staveteig S; Croft TN; Kampa KT; Head SK
PLoS One; 2017; 12(10):e0186316. PubMed ID: 29023510
[TBL] [Abstract][Full Text] [Related]
35. Hypertension among human immunodeficiency virus infected patients on treatment at Parirenyatwa Hospital: A descriptive study.
Chireshe R; Naidoo K; Nyamakura R
Afr J Prim Health Care Fam Med; 2019 Aug; 11(1):e1-e8. PubMed ID: 31478742
[TBL] [Abstract][Full Text] [Related]
36. Estimating the welfare gains from anti-retroviral therapy in Sub-Saharan Africa.
Da Costa S
J Health Econ; 2023 Jul; 90():102777. PubMed ID: 37329668
[TBL] [Abstract][Full Text] [Related]
37. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.
Mathers BM; Degenhardt L; Ali H; Wiessing L; Hickman M; Mattick RP; Myers B; Ambekar A; Strathdee SA;
Lancet; 2010 Mar; 375(9719):1014-28. PubMed ID: 20189638
[TBL] [Abstract][Full Text] [Related]
38. Global and regional trends of people living with HIV aged 50 and over: Estimates and projections for 2000-2020.
Autenrieth CS; Beck EJ; Stelzle D; Mallouris C; Mahy M; Ghys P
PLoS One; 2018; 13(11):e0207005. PubMed ID: 30496302
[TBL] [Abstract][Full Text] [Related]
39. Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review.
Adejumo OA; Malee KM; Ryscavage P; Hunter SJ; Taiwo BO
J Int AIDS Soc; 2015; 18(1):20049. PubMed ID: 26385853
[TBL] [Abstract][Full Text] [Related]
40. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
Bwire R; Nagelkerke NJ; Borgdorff MW
Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
